Memantina Flas Stadafarma (Memantine)

Memantine works by blocking the NMDA‑type glutamate receptors in the brain. This non‑competitive antagonism reduces excessive calcium influx that can cause neuronal injury, thereby limiting excitotoxic damage while preserving normal neurotransmission.

The specific dose of memantine is determined by the prescribing clinician based on the patient’s condition, age, renal function and other individual factors. Healthcare professionals adjust the regimen to achieve the desired therapeutic effect while monitoring safety.

Safety data for memantine in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision should be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

The primary alternative class for Alzheimer’s disease is acetylcholinesterase inhibitors such as donepezil. While those agents increase acetylcholine levels, memantine reduces glutamate‑mediated excitotoxicity. Both classes may be used together for complementary effects, but their mechanisms and side‑effect profiles differ.

Memantina Flas Stadafarma should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight and extreme temperatures to maintain its stability and potency.

The medication is taken orally, usually as a tablet or oral solution, as directed by the prescribing physician. It is typically swallowed with water and may be taken with or without food, depending on the clinician’s recommendation.

Serious adverse events include seizures, severe allergic reactions such as rash or angioedema, and hepatic dysfunction. Patients should be monitored for these signs, and treatment should be discontinued if any serious reaction occurs.

Memantine is contraindicated in individuals with known hypersensitivity to the drug. Caution is advised for patients with severe renal impairment, uncontrolled hypertension, or a history of seizures, as these conditions may increase the risk of adverse effects.